Thomas Hope, MD, Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, and Chief of Nuclear Medicine at the San Francisco VA Medical Center, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, January 20, 2022, from 12 noon to 1 pm, Eastern Time.
Dr. Hope’s main research focus is on novel imaging agents and therapies, particularly in neuroendocrine tumors and prostate cancer. He led the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Dr. Hope also leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and PSMA Radioligand Therapy at UCSF.
An international leader in PET/MR research and the translation of new molecular imaging agents, Dr. Hope launched the highly successful PSMA prostate program at UCSF and championed the use of multiple new targeted therapies to treat patients with neuroendocrine and other tumors. He currently serves as principal investigator on grants from the NIH and the Prostate Cancer Foundation. Dr. Hope is the recipient of numerous honors in molecular imaging, including the Henkin Fellow and Marc Tetalman Memorial Award from the Society of Nuclear Medicine and Molecular Imaging, the Young Investigator Award from the Prostate Cancer Foundation, and the Wylie J. Dodds Research Award from the Society of Abdominal Radiology.
Among the many publications for which Dr. Hope is a co-author are:
- The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
- Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
To learn more about the Neuroendocrine Tumor Program at UCSF, click here: https://neuroendocrine.ucsf.edu/.
To view the Luncheon with the Experts program come to CCF’s Facebook page, https://www.facebook.com/Carcinoid/, at noon Eastern Time. Registration is not necessary and there is no special link.
Viewers are welcome to pose questions during the live program.
The Facebook Live events are hosted by B. Rain Bennett, a longtime CCF filmmaker and dear friend of the NETs community.
If you are on Facebook but unable to join at the scheduled time, the presentations will remain permanently on CCF’s Facebook page in the Video section, https://www.facebook.com/pg/Carcinoid/videos/. You can view all of the 2020-2022 presentations at that link too.
And for anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
With special thanks to Ipsen Biopharmaceuticals, sponsor of the Luncheon with the Experts series. “At Ipsen, patients are the heart of our science.”
Sign up for our e-newsletter to receive notifications about all upcoming Luncheon with the Experts programs, every Thursday from noon to 1 pm ET, as well as lots of additional news of interest to the NET community: https://bit.ly/SignUpCCFe-news.